Lincoln Pharmaceuticals Ltd reports 28.33% rise in the Standalone Net Profit at Rs.11.85 crore in Q4 FY21
Company recommends dividend of 15% – Rs. 1.5 per share for FY 21 Net Revenues from operations in Q4FY21 at […] More
Lincoln Pharmaceuticals Ltd
Subterms
Latest stories
-
-
Promoters of Lincoln Pharma increases promoter group holding by 4.9% during FY 20-21 to 37.25%
Acquires 9.8 lakh shares from open market at average price of Rs. 225.6 per share. Highlights:- – ICRA in its […] More
-
-
ICRA upgrades rating and outlook of Lincoln Pharmaceuticals Ltd
ICRA has upgraded rating on long-term bank facilities to ICRA A and short-term facilities to ICRA A1 backed by steady […] More
-
Lincoln Pharmaceuticals Ltd reports 31 % rise in the Standalone Net Profit at Rs. 13.37 crore in Q3 FY21
February 02, 2021: Lincoln Pharmaceuticals Limited, one of India’s leading healthcare companies has reported net profit of Rs. 13.37 crore […] More
